- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Download Hennessy's Highlights® March 2024 edition
Hennessy's Highlights® features the latest oncology news From Mike Hennessy Jr, President & CEO of MJH Life Sciences.
The March 2023 issue, available for download below, contains:
- Early Phase Clinical Research Center Poised to Provide New Benefits in Hawaii and Beyond
- Outreach and Engagement: Colleagues Come Together to Improve Community Care
- Tampa General Hospital Cancer Institute Celebrates 2 Years of Growth and Innovation
- Metrics Report: Which of Your Peers Are Trending?
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
